NeuroPace, Inc.NPCENASDAQ
Loading
Year-over-year research & development expense growth
| Period | Value |
|---|---|
| Q4 2025 | 6.86% |
| Q3 2025 | -3.93% |
| Q2 2025 | -8.00% |
| Q1 2025 | 22.98% |
| Q4 2024 | 5.14% |
| Q3 2024 | -5.13% |
| Q2 2024 | 4.86% |
| Q1 2024 | 7.57% |
| Q4 2023 | 12.14% |
| Q3 2023 | -10.26% |
| Q2 2023 | 1.52% |
| Q1 2023 | 3.42% |
| Q4 2022 | -9.30% |
| Q3 2022 | -1.02% |
| Q2 2022 | 1.65% |
| Q1 2022 | 4.34% |
| Q4 2021 | 23.47% |
| Q3 2021 | -2.43% |
| Q2 2021 | 8.22% |
| Q1 2021 | 4.62% |
| Q4 2020 | 6.18% |
| Q3 2020 | 13.50% |
| Q2 2020 | -32.71% |
| Q1 2020 | 0.00% |